Literature DB >> 13679995

Anti-inflammatory properties of lipid oxidation products.

Valery N Bochkov1, Norbert Leitinger.   

Abstract

Oxidative modification of lipids occurs during inflammatory processes and leads to the formation and accumulation of biologically active lipid oxidation products that induce specific cellular reactions. These reactions lead to a modulation of the inflammatory process and may determine the fate and outcome of the body's reaction in acute inflammation during host defense. The processes by which oxidized lipids may play an important role include resolution of inflammation involving apoptosis, chronic inflammatory processes, and innate and adaptive immune responses. The classical view of lipid oxidation products is that they can induce and propagate chronic inflammatory reactions. However, evidence is accumulating that cells and tissues respond towards these oxidatively formed stress signals also by activation of anti-inflammatory processes. These include defense strategies such as (a) induction of signaling pathways leading to the upregulation of anti-inflammatory genes, (b) inhibition of signaling pathways coupled to the expression of proinflammatory genes, and (c) preventing the interaction of proinflammatory bacterial products with host cells. This contribution summarizes recent findings on the anti-inflammatory action of oxidized lipoproteins and lipid oxidation products. We discuss confirmed and suggested mechanisms as well as the (patho)physiological significance of these findings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679995     DOI: 10.1007/s00109-003-0467-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  143 in total

Review 1.  Biologically active oxidized phospholipids.

Authors:  T M McIntyre; G A Zimmerman; S M Prescott
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein.

Authors:  Aaron V Pontsler; Andy St Hilaire; Gopal K Marathe; Guy A Zimmerman; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2002-01-23       Impact factor: 5.157

3.  Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT.

Authors:  Valery N Bochkov; Diana Mechtcheriakova; Marcus Lucerna; Joakim Huber; Roland Malli; Wolfgang F Graier; Erhard Hofer; Bernd R Binder; Norbert Leitinger
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

4.  Inhibition of stimulus-induced endothelial cell intercellular adhesion molecule-1, E-selectin, and vascular cellular adhesion molecule-1 expression by arachidonic acid and its hydroxy and hydroperoxy derivatives.

Authors:  Z H Huang; E J Bates; J V Ferrante; C S Hii; A Poulos; B S Robinson; A Ferrante
Journal:  Circ Res       Date:  1997-02       Impact factor: 17.367

5.  Dualism of oxidized lipoproteins in provoking and attenuating the oxidative burst in macrophages: role of peroxisome proliferator-activated receptor-gamma.

Authors:  Barbara Fischer; Andreas von Knethen; Bernhard Brüne
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

6.  Core aldehydes of alkyl glycerophosphocholines in atheroma induce platelet aggregation and inhibit endothelium-dependent arterial relaxation.

Authors:  Hiroshi Kamido; Hiroyuki Eguchi; Hisao Ikeda; Tsutomu Imaizumi; Kazunari Yamana; Karsten Hartvigsen; Amir Ravandi; Arnis Kuksis
Journal:  J Lipid Res       Date:  2002-01       Impact factor: 5.922

7.  Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.

Authors:  H A Lehr; A S Weyrich; R K Saetzler; A Jurek; K E Arfors; G A Zimmerman; S M Prescott; T M McIntyre
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

8.  Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription.

Authors:  G C Parry; N Mackman
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

9.  Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury.

Authors:  Leo E Otterbein; Brian S Zuckerbraun; Manabu Haga; Fang Liu; Ruiping Song; Anny Usheva; Christina Stachulak; Natalya Bodyak; R Neal Smith; Eva Csizmadia; Shivraj Tyagi; Yorihiro Akamatsu; Richard J Flavell; Timothy R Billiar; Edith Tzeng; Fritz H Bach; Augustine M K Choi; Miguel P Soares
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

10.  Decreased inducibility of TNF expression in lipid-loaded macrophages.

Authors:  Mikko P S Ares; Maria Stollenwerk; Anneli Olsson; Bengt Kallin; Stefan Jovinge; Jan Nilsson
Journal:  BMC Immunol       Date:  2002-10-06       Impact factor: 3.615

View more
  26 in total

1.  Cross talk between paxillin and Rac is critical for mediation of barrier-protective effects by oxidized phospholipids.

Authors:  Anna A Birukova; Elena Alekseeva; Ivan Cokic; Christopher E Turner; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-01       Impact factor: 5.464

Review 2.  Lipid mediators in the regulation of endothelial barriers.

Authors:  Pratap Karki; Konstantin G Birukov
Journal:  Tissue Barriers       Date:  2017-10-30

Review 3.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

Review 4.  Oxidized lipids: the two faces of vascular inflammation.

Authors:  Konstantin G Birukov
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

5.  Novel modulatory effects of SDZ 62-434 on inflammatory events in activated macrophage-like and monocytic cells.

Authors:  Ji Yeon Lee; Man Hee Rhee; Jae Youl Cho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-26       Impact factor: 3.000

6.  Suppression of Toll-like receptor 4 activation by endogenous oxidized phosphatidylcholine, KOdiA-PC by inhibiting LPS binding to MD2.

Authors:  Min Jin Kim; Na Young Choi; Jung Eun Koo; So Young Kim; Sun Myung Joung; Eunshil Jeong; Joo Young Lee
Journal:  Inflamm Res       Date:  2013-03-09       Impact factor: 4.575

7.  Preventive effect of the flavonoid, wogonin, against ethanol-induced gastric mucosal damage in rats.

Authors:  Soojin Park; Ki-Baik Hahm; Tae-Young Oh; Joo-Hyun Jin; Ryowon Choue
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 8.  12/15-lipoxygenase during the regulation of inflammation, immunity, and self-tolerance.

Authors:  Stefan Uderhardt; Gerhard Krönke
Journal:  J Mol Med (Berl)       Date:  2012-09-15       Impact factor: 4.599

9.  Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury.

Authors:  Stephanie Nonas; Ian Miller; Kamon Kawkitinarong; Santipongse Chatchavalvanich; Irina Gorshkova; Valery N Bochkov; Norbert Leitinger; Viswanathan Natarajan; Joe G N Garcia; Konstantin G Birukov
Journal:  Am J Respir Crit Care Med       Date:  2006-03-02       Impact factor: 21.405

10.  Regulation of pentraxin-3 by antioxidants.

Authors:  A L Hill; D A Lowes; N R Webster; C C Sheth; N A R Gow; H F Galley
Journal:  Br J Anaesth       Date:  2009-10-28       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.